Serum concentrations and subcutaneous adipose tissue mRNA expression of omentin in morbid obesity and type 2 diabetes mellitus: The effect of very-low-calorie diet, physical activity and laparoscopic sleeve gastrectomy

Physiological Research

Volumn 63, Issue 2, 2014, Pages 207-218

  Urbanova M ^a   Dostalova I ^a   Trachta, P ^a   Drapalova J ^a   Kavalkova P ^a   Haluzikova D ^a   Matoulek, M ^a   Lacinova Z ^a   Mraz M ^a   Kasalicky M ^b   Haluzik M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Laparoscopic sleeve gastrectomy; Obesity; Omentin; Subcutaneous adipose tissue; Very low calorie diet

Indexed keywords

CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN; MESSENGER RNA;

ADULT; BIOSYNTHESIS; BLOOD; CALORIC RESTRICTION; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW UP; GASTRECTOMY; GENE EXPRESSION REGULATION; HUMAN; LAPAROSCOPY; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; OBESITY, MORBID; PHYSIOLOGY; PROCEDURES; SUBCUTANEOUS FAT;

ADULT; CALORIC RESTRICTION; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; GENE EXPRESSION REGULATION; GPI-LINKED PROTEINS; HUMANS; LAPAROSCOPY; LECTINS; MIDDLE AGED; MOTOR ACTIVITY; OBESITY, MORBID; RNA, MESSENGER; SUBCUTANEOUS FAT;

EID: 84899939562     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. AUGUET T, QUINTERO Y, RIESCO D, MORANCHO B, TERRA X, CRESCENTI A, BROCH M, AGUILAR C, OLONA M, PORRAS JA, HERNANDEZ M, SABENCH F, DEL CASTILLO D, RICHART C: New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet 12: 60, 2011.
2. BAGLIONI S, CANTINI G, POLI G, FRANCALANCI M, SQUECCO R, DI FRANCO A, BORGOGNI E, FRONTERA S, NESI G, LIOTTA F, LUCCHESE M, PERIGLI G, FRANCINI F, FORTI G, SERIO M, LUCONI M: Functional differences in visceral and subcutaneous fat pads originate from differences in the adipose stem cell. PLoS One 7: e36569, 2012.
3. BARTH S, KLEIN P, HORBACH T, DÖTSCH J, RAUH M, RASCHER W, KNERR I: Expression of neuropeptide Y, omentin and visfatin in visceral and subcutaneous adipose tissue in humans: relation to endocrine and clinical parameters. Obes Facts 3: 245-251, 2010.
4. BATRA A, SIEGMUND B: The role of visceral fat. Dig Dis 30: 70-74, 2012.
5. BLÜHER M: Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes 117: 241-250, 2009.
6. BLÜHER M: Clinical relevance of adipokines. Diabetes Metab J 35: 317-327, 2012.
7. BOSE M, OLIVÁN B, TEIXEIRA J, PI-SUNYER FX, LAFERRÉRE B: Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence? Obes Surg 19: 217-229, 2009.
8. CHOI JH, RHEE EJ, KIM KH, WOO HY, LEE WY, SUNG KC: Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome. Eur J Endocrinol 165: 789-796, 2011.
9. DE SOUZA BATISTA CM, YANG RZ, LEE MJ, GLYNN NM, YU DZ, PRAY J, NDUBUIZU K, PATIL S, SCHWARTZ A, KLINGMAN M, FRIED SK, GONG DW, SHULDINER AR, POLLIN TI, MCLENITHAN JC: Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56: 1655-1661, 2007.
10. DESPRÉS JP, LEMIEUX I, BERGERON J, PIBAROT P, MATHIEU P, LAROSE E, RODÉS-CABAU J, BERTRAND OF, POIRIER P: Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 28: 1039-1049, 2008.
11. DOLINKOVA M, DOSTALOVA I, LACINOVA Z, MICHALSKY D, HALUZIKOVA D, MRÁZ M, KASALICKY M, HALUZIK M: The endocrine profile of subcutaneous and visceral adipose tissue of obese patients. Mol Cell Endocrinol 291: 63-70, 2008.
12. FIELD AE, COAKLEY EH, MUST A, SPADANO JL, LAIRD N, DIETZ WH, RIMM E, COLDITZ GA: Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 161: 1581-1586, 2001.
13. FUJITA K, NISHIZAWA H, FUNAHASHI T, SHIMOMURA I, SHIMABUKURO M: Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J 70: 1437-1442, 2006.
14. GUH DP, ZHANG W, BANSBACK N, AMARSI Z, BIRMINGAHM CL, ANIS AH: The incidence of co-morbidities related to obesity and overweight: A systemic review and meta-analysis. BMC Public Health 9: 88, 2009.
15. GUO LJ, JIANG TJ, LIAO L, LIU H, HE HB: Relationship between serum omentin-1 level and bone mineral density in girls with anorexia nervosa. J Endocrinol Invest 36: 190-194, 2013.
16. HASLAM DW, JAMES WP: Obesity. Lancet 366: 1197-1209, 2005.
17. HOTAMISLIGIL GS: Inflammation and metabolic disorders. Nature 444: 860-867, 2006.
18. INDULEKHA K, ANJANA RM, SURENDAR J, MOHAN V: Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113). Clin Biochem 44: 281-287, 2011.
19. JIALAL I, DEVARAJ S, KAUR H, ADAMS-HUET B, BREMER AA: Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. J Clin Endocrinol Metab 98: E514-E517, 2013.
20. MORENO-NAVARRETE JM, CATALÁN V, ORTEGA F, GÓMEZ-AMBROSI J, RICART W, FRÜHBECK G, FERNÁNDEZ-REAL JM: Circulating omentin concentration increases after weight loss. Nutr Metab 7: 27, 2010.
21. MRÁZ M, LACINOVA Z, DRAPALOVA J, HALUZIKOVA D, HORINEK A, MATOULEK M, TRACHTA P, KAVALKOVA P, SVACINA S, HALUZIK M: The effect of very-low calorie diet on mRNA expression of inflammation-related genes in subcutaneous adipose tissue and peripheral monocytes of obese patients with type 2 diabetes mellitus. J Clin Endocrionl Metab 96: 606-613, 2011.
22. KRALISCH S, KLIEUN J, BLUHER M, PASCHKE R, STUMVOLL M, FASSHAUER M: Therapeutic perspectives of adipocytokines. Expert Opin Pharmacother 6: 863-872, 2005.
23. PAN HY, GUO L, LI Q: Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract 88: 29-33, 2010.
24. SAREMI A, ASGHARI M, GHORBANI A: Effects of aerobic training on serum omentin-1 and cardiometabolic risk factors in overweight and obese men. J Sports Sci 28: 993-998, 2010.
25. SCHÄFFLER A, NEUMEIER M, HERFARTH H, FÜRST A, SCHÖLMERICH J, BÜCHLER C: Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 1732: 96-102, 2005.
26. SELL H, HABICH C, ECKEL J: Adaptive immunity in obesity and insulin resistance. Nat Rev Endocrinol 8: 709-716, 2012.
27. SHOELSON SE, LEE J, GOLDFINE AB: Inflammation and insulin resistance. J Clin Invest 116: 1793-1801, 2006.
28. STUMVOLL M, GOLDSTEIN BJ, VAN HAEFTEN TW: Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365: 1333-1346, 2005.
29. TOUSKOVA V, TRACHTA P, KAVALKOVA P, DRAPALOVA J, HALUZIKOVA D, MRAZ M, LACINOVA Z, MAREK J, HALUZIK M: Serum concentrations and tissue expression of components of insulin-like growth factor-axis in females with type 2 diabetes mellitus and obesity: The influence of very-low-calorie diet. Mol Cell Endocrinol 361: 172-178, 2012.
30. WAJCHENBERG BL: Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21: 697-738, 2000.
31. YAN P, LIU D, LONG M, REM Y, PANG J, LI R: Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 119: 257-263, 2011.
32. YANG RZ, LEE MJ, HU H, PRAY J, WU HB, HANSEN BC, SHULDINER AR, FRIED SK, MCLENITHAN JC, GONG DW: Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 290: E1253-E1261, 2006.
33. ZEYDA M, STULNIG TM: Obesity, inflammation, and insulin resistance - a mini-review. Gerontology 55: 379-386, 2009.
34. ZHOU JY, CHAN L, ZHOU SW: Omentin: Linking metabolic syndrome and cardiovascular disease. Curr Vasc Pharmacol, 2012 (in press)